Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today announced the ...

For decades, aging has been regarded as a sign of irreversible pathologies, weakness, and dependence. Anti-aging remedies ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from ...

Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...

Learn moreThe best cheap cell phone plans offer all the following criteria without compromise: reliable coverage, fast speeds ...

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...

Mattress pads can end up with stains, smells and even dust mites. Here’s a step-by-step guide for how to clean them, no ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...